Status:
COMPLETED
Integrated Smoking Cessation Treatment for Low Income Community Corrections
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Smoking Cessation
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
This study recruited cigarette smokers under supervision in community corrections (e.g., probation, parole, drug courts, etc.) in the Birmingham, Alabama area. Smokers received 12 weeks of bupropion t...
Eligibility Criteria
Inclusion
- At least 19 years or older
- Enrolled in criminal justice community supervision (e.g., probation, parole, drug court, community corrections, etc)
- Smoking at least 5 cpd for the past year
- Maintained in an unrestricted environment (e.g., not currently in a correctional facility or treatment facility) living in the Birmingham Area and surrounding communities
Exclusion
- Pregnant or nursing (all women in this study will be required to use an acceptable form of contraception throughout the administration of the medication)
- Known sensitivity to Zyban or Wellbutrin
- History of seizures
- Current or prior anorexia or bulimia
- Abrupt withdrawal from alcohol or benzodiazepines
- Moderate to severe kidney problems
- Moderate liver problems
- Cognitive impairment such that they cannot provide informed consent
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
689 Patients enrolled
Trial Details
Trial ID
NCT01257490
Start Date
October 1 2009
End Date
March 1 2014
Last Update
April 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB Substance Abuse
Birmingham, Alabama, United States, 35209